Eran Broshy is Director at VENTIV HEALTH INC (VTIV). They have made 6 open-market trades across 4 companies since 2007, most recently 2026-05-14.
CIK 0001256230
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $981K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TBPH | 60,204 | $1.0M |
| MGLN | 9,645 | $916K |
| CERT | 50,708 | $476K |
| VTIV | 249,856 | — |
| Total | $2.4M |
Shares reported on the most recent Form 4, priced at the 2026-05-15 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TBPH | SELL · 10b5-1 | 2025-11-26 | 2025-12-01 | $20.00 | $590K | -10.1% | -4.9% | -3.7% |
| TBPH | SELL | 2025-11-11 | 2025-11-14 | $18.50 | $287K | +13.3% | +0.9% | +10.1% |
| CERT | BUY | 2023-08-21 | 2023-08-23 | $15.81 | $155K | -8.0% | -13.8% | -11.7% |
| MGLN | SELL | 2017-02-23 | 2017-02-27 | $80.00 | $389K | -2.4% | -5.1% | -2.1% |
| MGLN | SELL | 2016-12-08 | 2016-12-12 | $75.00 | $182K | -2.9% | +1.7% | -11.2% |
| VTIV | BUY | 2010-06-15 | 2010-06-17 | $25.15 | $574K | N/A | N/A | N/A |
| VTIV | BUY | 2008-08-12 | 2008-08-14 | $18.04 | $253K | N/A | N/A | N/A |
| VTIV | SELL · 10b5-1 | 2007-07-16 | 2007-07-18 | $38.11 | $1.7M | N/A | N/A | N/A |
| VTIV | SELL · 10b5-1 | 2007-07-06 | 2007-07-10 | $37.82 | $1.4M | N/A | N/A | N/A |
| VTIV | SELL · 10b5-1 | 2007-06-14 | 2007-06-18 | $37.24 | $2.0M | N/A | N/A | N/A |
| VTIV | SELL · 10b5-1 | 2007-05-22 | 2007-05-24 | $37.75 | $1.6M | N/A | N/A | N/A |
| VTIV | SELL · 10b5-1 | 2007-05-14 | 2007-05-16 | $38.37 | $1.8M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.